Effective bioprocess development starts with the targeted and time-saving generation of high-productivity...
Up To Date
Backgrounds & Stories
The future of AAV vector-based therapies holds great promise if manufacturers can cope with the demand. While...
The German Patent System has been a very patentee-friendly system, in particular for smaller patentees....
Study start-up is a chaotic time. There are lots of moving parts. Lots of decisions to make and processes to...
Africa produces less than 1% of the human vaccines it uses. To effectively respond in time of outbreaks and...
IP – In a recent decision (Royalty vs. DPMA; C-650/17), the European Court of Justice (ECJ) has shed some...
Share
